Varian’s blog about breakthroughs, resources, and expert insights for Interventional Radiology professionals.

AUA Guidelines for PAE: Hope for Silent Sufferers?

Dr. Charles Nutting is seeing an upswing in the number of patients asking about PAE and believes the latest AUA guidelines are likely to result in more PAE procedures as patients, urologists, and general practitioners realize its benefits as an alternative minimally invasive treatment for suitable patients.

The Future of Microwave Ablation of Primary and Metastatic Liver Cancer

The role of microwave ablation (MWA) for the treatment of hepatocellular carcinoma and metastatic liver cancer has broadened based on positive clinical studies demonstrating its effectiveness and safety compared to other thermal ablation technologies.

Varian Offering Science-Based Education Programs for the Community of Interventional Radiologists

Varian’s Interventional Solutions business is more than four years into building a best-in-class multi-faceted education program for the worldwide community of interventional radiologists.

Microwave Ablation Protocol for Liver Metastases to be Studied Across Centers Worldwide

Over the past decade or so, evidence continues to accrue that image-guided microwave ablation is a viable approach to treating metastatic colorectal cancer.

Varian Welcomes Theresa Caridi, MD, as Medical Director for Interventional Solutions

Theresa Caridi, MD, FSIR, Clinical Associate Professor of Interventional Radiology (IR) at the University of Alabama at Birmingham (UAB), has joined Varian as Medical Director for Varian Interventional Solutions.

New Studies Set to Investigate the Potential of GAE for the Treatment of Knee Osteoarthritis

Interventional radiology is one of the most exciting and expanding areas for innovations in advancing healthcare. As clinicians and researchers seek less invasive and more personalized approaches to illness and disease, high-quality studies on image-guided procedures, such as ablation and embolization, become ever more critical.

Cryoablation Innovation Shows Promising Real-World Results

Navid Eghbalieh, MD, Medical Director of Vascular & Interventional Radiology at Providence Holy Cross Medical Center, and Assistant Clinical Professor of Vascular & Interventional Radiology at UCLA, shared his experiences with the Varian CryoCare system using the V-PROBE® cryoprobe in two recent case studies.

Varian Expands Cancer Care Solutions Portfolio with Interventional Oncology Acquisitions

Varian has acquired Endocare® Systems, based in Austin, Texas; and Alicon, based in Hangzhou, China. Endocare is a leading provider of technology for cryoablation and microwave ablation. In China, Alicon is a leader in embolic therapy agents for treating liver cancer.